Abstract Library

#1456 Retreatment with Peptide-Receptor Radionuclide Therapy: Effects on Long-term Survival, Renal and Bone Marrow Toxicity Using Yttrium-90 vs. Lutetium-177

Introduction: PRRT is an effective treatment for metastatic NETs. The effect of PRRT retreatment is unknown.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Machta J

Authors: Machta J, Caplin M, Toumpanakis C, Mohmaduvesh M, Garcia-Hernandez J,

Keywords: PRRT, retreatment,

#1416 Efficacy of Peptide Receptor Radionuclide Therapy in Patients with Advanced Bronchial Neuroendocrine Tumours

Introduction: There is not established treatment pathway in advanced bronchial neuroendocrine tumours(bNETs).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Koffas A

Authors: Koffas A, Popat R, Mohmaduvesh M, Quigley A, Navalkissoor S,

Keywords: PRRT,bronchial NETs,

#768 Long-Term Haematological and Renal Toxicity of 90Yttrium-DOTA-Octreotate in the Treatment of Advanced Neuroendocrine Tumors(NETs)

Introduction: Peptide receptor radiation therapy (PRRT) is an established treatment for advanced NETs. Renal/haematological toxicity are recognised adverse effects.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: MELVILLE A

Authors: Melville A, Cheung V, Garcia-Hernandez J, Pericleous M, Navalkissoor S,

Keywords: NET, PRRT, renal toxicity, bone marrow toxicity, Yttrium90,